MARKETS
Earnings

Rockwell Medical Affirms FY2026 Sales Guidance of $70.000M-$75.000M vs $72.469M Est

Aug 13, 2026 · 06:01 AM ET· updated 1h ago

Rockwell Medical (NASDAQ:RMTI) affirms FY2026 sales outlook from $70.000 million-$75.000 million to $70.000 million-$75.000 million vs $72.469 million estimate.

Share
Why It Matters

Rockwell Medical said their expected sales for next year will be between $70–$75 million, staying the same as before. When a company keeps its outlook steady, it means they feel confident about their plans, even if the guess is a bit lower than what some people expected.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.